Senores Pharmaceuticals Ltd vs Zim Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 1136 as of 10 Jun 10:56 . The P/E Ratio of Senores Pharmaceuticals Ltd changed from 45 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Zim Laboratories Ltd changed from 16.1 on March 2021 to 54.9 on March 2026 . This represents a CAGR of 22.68% over 6 years The Market Cap of Senores Pharmaceuticals Ltd changed from ₹ 2637 crore on March 2025 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe Market Cap of Zim Laboratories Ltd changed from ₹ 117.75 crore on March 2021 to ₹ 320.31 crore on March 2026 . This represents a CAGR of 18.15% over 6 years The revenue of Senores Pharmaceuticals Ltd for the Mar '26 is ₹ 192.86 crore as compare to the Dec '25 revenue of ₹ 178.34 crore. This represent the growth of 8.14% The revenue of Zim Laboratories Ltd for the Mar '26 is ₹ 111.44 crore as compare to the Dec '25 revenue of ₹ 110.36 crore. This represent the growth of 0.98% The ebitda of Senores Pharmaceuticals Ltd for the Mar '26 is ₹ 65.16 crore as compare to the Dec '25 ebitda of ₹ 57.79 crore. This represent the growth of 12.75% The ebitda of Zim Laboratories Ltd for the Mar '26 is ₹ 13.35 crore as compare to the Dec '25 ebitda of ₹ 14.51 crore. This represent the decline of -7.99% The net profit of Senores Pharmaceuticals Ltd changed from ₹ 10.91 crore to ₹ 36.67 crore over 8 quarters. This represents a CAGR of 83.33% The net profit of Zim Laboratories Ltd changed from ₹ 0.9 crore to ₹ 3.74 crore over 8 quarters. This represents a CAGR of 103.85% The Dividend Payout of Senores Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
The Regulated Markets business is focused on Regulated Markets of US and Canada.
The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

About Zim Laboratories Ltd

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra.
The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company.
SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

FAQs for the comparison of Senores Pharmaceuticals Ltd and Zim Laboratories Ltd

Which company has a larger market capitalization, Senores Pharmaceuticals Ltd or Zim Laboratories Ltd?

Market cap of Senores Pharmaceuticals Ltd is 5,037 Cr while Market cap of Zim Laboratories Ltd is 581 Cr

What are the key factors driving the stock performance of Senores Pharmaceuticals Ltd and Zim Laboratories Ltd?

The stock performance of Senores Pharmaceuticals Ltd and Zim Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Senores Pharmaceuticals Ltd and Zim Laboratories Ltd?

As of June 10, 2026, the Senores Pharmaceuticals Ltd stock price is INR ₹1093.75. On the other hand, Zim Laboratories Ltd stock price is INR ₹108.6.

How do dividend payouts of Senores Pharmaceuticals Ltd and Zim Laboratories Ltd compare?

To compare the dividend payouts of Senores Pharmaceuticals Ltd and Zim Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.